Massachusetts Institute of Technology
Department of Biology Headquarters, Building 68-13
77 Massachusetts Avenue
Cambridge
Massachusetts
02139-4307
United States
Tel: 617-253-4701
Fax: 617-253-8699
Website: http://www.mit.edu/
Email: mitbiohq@mit.edu
About Massachusetts Institute of Technology
The mission of MIT is to advance knowledge and educate students in science, technology and other areas of scholarship that will best serve the nation and the world in the 21st century.The Institute is committed to generating, disseminating and preserving knowledge, and to working with others to bring this knowledge to bear on the world's great challenges. MIT is dedicated to providing its students with an education that combines rigorous academic study and the excitement of discovery with the support and intellectual stimulation of a diverse campus community. We seek to develop in each member of the MIT community the ability and passion to work wisely, creatively and effectively for the betterment of humankind.
Last Updated: 07-08-03
639 articles with Massachusetts Institute of Technology
-
Dr. Anikeeva, a neural engineer, is an Associate Investigator at the McGovern Institute for Brain Research at Massachusetts Institute of Technology (MIT). She's an Associate Professor of Materials Science, Engineering, and Brain and Cognitive Sciences as well as an Associate Director of the Resea...
-
The idea of swallowing a needle seems like a very bad idea. But a research team at MIT has developed a capsule about the size of a blueberry that holds a tiny needle that, after being swallowed, injects insulin into the stomach.
-
Eugene A. Fitzgerald Appointed SMART CEO & Director
2/1/2019
Eugene A. Fitzgerald has been appointed Chief Executive Officer and Director of the Singapore-MIT Alliance for Research and Technology, MIT’s research enterprise in Singapore established in partnership with the National Research Foundation of Singapore.
-
Crafoord Prize Awarded for Discovery of Miniscule Organism
1/18/2019
This year's Crafoord Prize has been awarded to Sallie Chisholm for the discovery of and research into Prochlorococcus, a very small cyanobacteria of huge importance.
-
January 11 Research Roundup: Inhalable mRNA, CRISPR and Muscular Dystrophy, Do-It-Yourself DNA De...
1/11/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
December 21 Research Roundup: HIV Vaccine, Super-Accurate Cervical Cancer Test, Molecular Mechani...
12/21/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
The American Society of Hematology is holding its 60th Annual Meeting & Exposition starting December 1 and running through December 4 in San Diego. Most of the players, big and small, in cancer drug therapies will be there, presenting updates and breaking stories about their hematology pipelines.
-
November 30 Research Roundup: CRISPR Embryos, Brain-Computer Interface, ADHD Genetic Variants and...
11/30/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. Although most readers will already be aware of it, the biggest story, perhaps the biggest story of the year—certainly the most controversial—involves a Chinese researcher who used CRISPR to m... -
Many of these directors do not publicly disclose their affiliation with the pharma companies in their nonprofit biographies, report shows.
-
New Research Identifies Genetic Variants Linked Separately to ADHD and Autism Speech Issues
11/29/2018
Scientists from a consortium of prominent research institutions studied the entire genomes of more than 20,000 people with attention deficit/hyperactivity disorder (ADHD) and compared them to the genomes of 35,000 who did not have ADHD. They identified 12 genetic variants in the ADHD group, sugge... -
Every year, Forbes creates a list of 30 Under 30, people under the age of 30 who have made a mark and show promise in various areas. They just came out with the 2019 30 Under 30: Healthcare. Here we highlight a dozen of the winners for their roles in biopharma-related endeavors.
-
Yesterday, researchers at the Massachusetts Institute of Technology (MIT) published research in the journal Science Advances describing yet another CRISPR improvement.
-
Every year, the Breakthrough Prize Foundation awards a collective total of $22 million to nine researchers for achievements in the Life Sciences, Fundamental Physics and Mathematics.
-
Recently, 23andMe partnered with GlaxoSmithKline, causing the Forbes Technology Council to cite eight ways these types of partnerships will affect disease treatments. These types of partnerships aren’t exactly new.
-
Trovagene Announces Exclusive License Agreement with MIT for Combination Therapy of Anti-Androgens and Polo-like Kinase Inhibitors in Prostate Cancer
10/3/2018
Patent agreement covers rights to develop combination therapies and identified predictive clinical biomarker across cancer types, expanding indications for Onvansertib
-
Watertown, Massachusetts-based Lyra Therapeutics closed a Series B financing worth $29.5 million. Its lead compound is LYR-210, which the company plans to take into a Phase II clinical trial for chronic rhinosinusitis
-
It was a win for the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University, as a federal court of appeals ruled against the University of California (UC) on CRISPR patents.
-
In another example of companies focused on aging-related diseases, Elevian launched with $5.5 million in seed funding. Elevian’s founders came out of Stanford and then Harvard, focused on regenerative effects of “young blood.”
-
RootPath, headquartered in Cambridge, Massachusetts, announced a $7 million seed funding round. The financing was led by Sequoia China. Volcanics Venture, BV (Baidu Ventures) and NestBio Ventures participated.
-
Merus Announces Formation of a Scientific Advisory Board
8/22/2018
Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced the formation of a Scientific Advisory Board (SAB), consisting of several world-renowned immuno-oncology and drug development professionals.